These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37824248)

  • 1. Epidemiology of common infectious diseases before and during the COVID-19 pandemic in Bavaria, Germany, 2016 to 2021: an analysis of routine surveillance data.
    van de Berg S; Charles T; Dörre A; Katz K; Böhm S
    Euro Surveill; 2023 Oct; 28(41):. PubMed ID: 37824248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020.
    Ullrich A; Schranz M; Rexroth U; Hamouda O; Schaade L; Diercke M; Boender TS;
    Lancet Reg Health Eur; 2021 Jul; 6():100103. PubMed ID: 34557831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of common infectious diseases in Japan during the COVID-19 pandemic.
    Hibiya K; Iwata H; Kinjo T; Shinzato A; Tateyama M; Ueda S; Fujita J
    PLoS One; 2022; 17(1):e0261332. PubMed ID: 35020724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
    JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
    Du M; Wang R; Yuan J; Lv X; Yan W; Liu Q; Qin C; Xiang N; Zhu L; Liang W; Liu M; Liu J
    J Med Virol; 2023 Jan; 95(1):e28353. PubMed ID: 36443103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.
    Sawakami T; Karako K; Song P; Sugiura W; Kokudo N
    Biosci Trends; 2021 Sep; 15(4):257-261. PubMed ID: 34261848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common communicable diseases in the general population in France during the COVID-19 pandemic.
    Launay T; Souty C; Vilcu AM; Turbelin C; Blanchon T; Guerrisi C; Hanslik T; Colizza V; Bardoulat I; Lemaître M; Boëlle PY
    PLoS One; 2021; 16(10):e0258391. PubMed ID: 34634090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
    Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
    BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate and long-term changes in infectious diseases in China at the "First-level-response", "Normalized-control" and "Dynamic-COVID-zero" stages from 2020 to 2022: a multistage interrupted-time-series-analysis.
    Shi T; Zhang X; Meng L; Li D; Jin N; Zhao X; Zheng H; Wang T; Li R; Ren X
    BMC Public Health; 2023 Jul; 23(1):1381. PubMed ID: 37464368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.
    Li K; Rui J; Song W; Luo L; Zhao Y; Qu H; Liu H; Wei H; Zhang R; Abudunaibi B; Wang Y; Zhou Z; Xiang T; Chen T
    Nat Commun; 2024 May; 15(1):3891. PubMed ID: 38719858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of voluntary human mobility restrictions on vector-borne diseases during the COVID-19 pandemic in Japan: A descriptive epidemiological study using a national database (2016 to 2021).
    Hibiya K; Shinzato A; Iwata H; Kinjo T; Tateyama M; Yamamoto K; Fujita J
    PLoS One; 2023; 18(5):e0285107. PubMed ID: 37228070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of the pandemic on various infectious diseases with different epidemiological patterns of seasonality, transmission and age].
    Gascó-Laborda JC; Tirado-Balaguer MD; Gil-Fortuño M; Dorina Deaconescu G; Sabalza-Baztán O; Pérez-Olaso Ó; Gómez-Alfaro I; Hernández-Pérez N; Bellido-Blasco JB
    Rev Esp Salud Publica; 2024 Feb; 98():. PubMed ID: 38385502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing Patterns of Infectious Diseases Among Hospitalized Children in Hokkaido, Japan, in the Post-COVID-19 Era, July 2019 to June 2022.
    Fukuda Y; Togashi A; Hirakawa S; Yamamoto M; Fukumura S; Nawa T; Honjo S; Kunizaki J; Nishino K; Tanaka T; Kizawa T; Yamamoto D; Takeuchi R; Sasaoka Y; Kikuchi M; Ito T; Nagai K; Asakura H; Kudou K; Yoshida M; Nishida T; Tsugawa T
    Pediatr Infect Dis J; 2023 Sep; 42(9):766-773. PubMed ID: 37257096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on infectious disease hospitalizations of neonates at a tertiary academic hospital: a cross-sectional study.
    Pan J; Zhan C; Yuan T; Sun Y; Wang W; Chen L
    BMC Infect Dis; 2022 Mar; 22(1):206. PubMed ID: 35236317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis.
    Lai CC; Chen SY; Yen MY; Lee PI; Ko WC; Hsueh PR
    Travel Med Infect Dis; 2021; 40():101997. PubMed ID: 33640476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of the COVID-19 pandemic on the occurrence of neurological infectious diseases].
    Völk S; Ködel U; Pfister HW; Klein M
    Nervenarzt; 2023 Apr; 94(4):278-286. PubMed ID: 36576523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
    Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
    Front Public Health; 2021; 9():728768. PubMed ID: 34722440
    [No Abstract]   [Full Text] [Related]  

  • 20. Infectious diseases in Poland in 2020.
    Rosińska M; Czarkowski MP; Sadkowska-Todys M
    Przegl Epidemiol; 2022; 76(4):514-527. PubMed ID: 37017226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.